Name (brand and/ or generic name) |
Manufacturer | Dose used | Route used | Frequency | |
---|---|---|---|---|---|
1.* |
|
|
|
|
|
2. |
|
|
|
|
|
3. |
|
|
|
|
|
4. |
|
|
|
|
|
Batch No./Lot No. | Exp. Date (If known) | Therapy dates (if unknown, give duration) | Reason for Use or prescribed for | ||
---|---|---|---|---|---|
Date started | Date stopped | ||||
1.* |
|
|
|
|
|
The Therapy started Date should always be prior to the Stop Date | |||||
The Therapy stop Date should always be prior to Recovery Date | |||||
Therapy Start date must be on or before Reaction Start date in Section B. | |||||
2. |
|
|
|
|
|
The Therapy started Date should always be prior to the Stop Date | |||||
The Therapy stop Date should always be prior to Recovery Date | |||||
Therapy Start date must be on or before Reaction Start date in Section B. | |||||
3. |
|
|
|
|
|
The Therapy started Date should always be prior to the Stop Date | |||||
The Therapy stop Date should always be prior to Recovery Date | |||||
Therapy Start date must be on or before Reaction Start date in Section B. | |||||
4. |
|
|
|
|
|
The Therapy started Date should always be prior to the Stop Date | |||||
The Therapy stop Date should always be prior to Recovery Date | |||||
Therapy Start date must be on or before Reaction Start date in Section B. |
Reaction abated after drug stopped or dose reduced :
Reaction reappeared after reintroduction :
Seriousness of the reaction *:
Outcomes * :
If you would like to send us information by post, please download the form here and mail to the following address:
Download Adverse Drug Reaction Reporting Form Adverse Drug Reaction Reporting Form
Pharmacovigilance Cell
31, Race Course Road, Bangalore-560001
Phone No : 080-22343023
E-mail : drugsafety@microlabs.in
Website : www.microlabsltd.com
Report adverse experiences with medications
Report serious adverse reactions. A reaction is serious when the patient outcome is:
Report even if:
Who can report:
Where to report:
What happens to the submitted information:
The patient's identity is held in strict confidence and protected to the fullest extent. Programme staff is not expected to and will not disclose the reporter's identity in response to a request from the public. Submission of a report does not constitute an admission that medical personnel or manufacturer or the product caused or contributed to the reaction.